These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 36091531)
1. HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: Results from a prospective observational study in Germany. Uhrmacher M; Skaletz-Rorowski A; Nambiar S; Schmidt AJ; Ahaus P; Serova K; Mordhorst I; Kayser A; Wach J; Tiemann C; Münstermann D; Brockmeyer NH; Potthoff A Front Public Health; 2022; 10():930208. PubMed ID: 36091531 [TBL] [Abstract][Full Text] [Related]
2. The impact of COVID-19-related restrictions in 2020 on sexual healthcare use, pre-exposure prophylaxis use, and sexually transmitted infection incidence among men who have sex with men in Amsterdam, the Netherlands. de la Court F; Boyd A; Coyer L; van den Elshout M; de Vries HJC; Matser A; Hoornenborg E; Prins M; HIV Med; 2023 Feb; 24(2):212-223. PubMed ID: 36226479 [TBL] [Abstract][Full Text] [Related]
3. Low incidence of HIV infection and decreasing incidence of sexually transmitted infections among PrEP users in 2020 in Germany. Schmidt D; Kollan C; Bartmeyer B; Bremer V; Schikowski T; Friebe M; Schellberg S; Scholten S; Bickel M; Hanhoff N; Rüsenberg R; Schewe K; Infection; 2023 Jun; 51(3):665-678. PubMed ID: 36168098 [TBL] [Abstract][Full Text] [Related]
4. Seroconversion rate of SARS-CoV-2 IgG antibodies and dating behaviour in HIV-PrEP users in a German metropolis during the COVID-19 pandemic. Weidlich S; Schneider J; Lee M; Mijočević H; Graf N; Protzer U; Spinner C; Noe S Int J STD AIDS; 2023 Nov; 34(13):956-961. PubMed ID: 37461288 [TBL] [Abstract][Full Text] [Related]
5. PrEP Use and Persistence Among Young Sexual Minority Men 17-24 Years Old During the COVID-19 Pandemic. Hong C; Horvath KJ; Stephenson R; Nelson KM; Petroll AE; Walsh JL; John SA AIDS Behav; 2022 Mar; 26(3):631-638. PubMed ID: 34387777 [TBL] [Abstract][Full Text] [Related]
6. HIV pre-exposure prophylaxis and diagnoses of sexually transmitted infections - observational data from German checkpoints, 01/2019-08/2021. Marcus U; Schink SB; Weber C BMC Public Health; 2023 Apr; 23(1):661. PubMed ID: 37029369 [TBL] [Abstract][Full Text] [Related]
7. COVID-19 restrictions and changing sexual behaviours in HIV-negative MSM at high risk of HIV infection in London, UK. Hyndman I; Nugent D; Whitlock GG; McOwan A; Girometti N Sex Transm Infect; 2021 Nov; 97(7):521-524. PubMed ID: 33462118 [TBL] [Abstract][Full Text] [Related]
8. [Sexual behavior and prevention of sexually transmitted infections taking the SARS-CoV-2 pandemic into account. Data from a sexual healthcare and medicine center-WIR]. Brockmeyer NH; Potthoff A; Knebel-Brockmeyer W; Köhler B; Nambiar S; Wach J; Rodrigues Martins T; Uhrmacher M; Schuppe AK; Tiemann C; Kasper A; Basilowski M; Kayser A; Skaletz-Rorowski A Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Nov; 64(11):1440-1451. PubMed ID: 34665268 [TBL] [Abstract][Full Text] [Related]
9. Impact of the Early COVID-19 Pandemic on the Number of HIV Preexposure Prophylaxis Uses and the Proportion of Preexposure Prophylaxis Users Receiving Sexually Transmitted Infection Testing Services. Schmidt MA; Salas SB; Donald JL; Gift TL; Tao G Sex Transm Dis; 2023 May; 50(5):304-309. PubMed ID: 36730891 [TBL] [Abstract][Full Text] [Related]
10. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study. Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC; Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284 [TBL] [Abstract][Full Text] [Related]
11. Changes in mental and sexual health among MSM using HIV pre-exposure prophylaxis during the SARS-CoV-2 pandemic: longitudinal analysis of the SwissPrEPared cohort study. Winter BL; Hovaguimian F; Kouyos RD; Schmidt AJ; Bernasconi E; Braun DL; Calmy A; Notter J; Stoeckle M; Surial B; Christinet V; Cavassini M; Depmeier C; Läuchli S; Boffi El Amari E; Reinacher M; Rasi M; Bruggmann P; Haerry D; Bize R; Low N; Lehner A; Quednow BB; Fehr JS; Hampel B Swiss Med Wkly; 2022 Jun; 152():w30192. PubMed ID: 35758418 [TBL] [Abstract][Full Text] [Related]
12. [Evaluating the introduction of HIV pre-exposure prophylaxis as a benefit of statutory health insurance (EvE-PrEP) : Highly effective protection against HIV without an increase in sexually transmitted infections]. Schmidt D; Kollan C; Schewe K; Hanhoff N; Rüsenberg R; Friebe M; Schikowski T; Schink SB; Marcus U; Koppe U; Jansen K; Streeck H; Ottensmeyer P; An der Heiden M; Bannert N; M'Bayo R; Ceres M; Weber L; Sweers H; Schmidt AJ; Tietz H; Danan E; Bendig J; Kloep S; Neumann A; Valbert F; Wasem J; Bartmeyer B; Bremer V; Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Sep; 66(9):1008-1018. PubMed ID: 37436444 [TBL] [Abstract][Full Text] [Related]
13. Changes in Sexual Behavior, PrEP Adherence, and Access to Sexual Health Services Because of the COVID-19 Pandemic Among a Cohort of PrEP-Using MSM in the South. Pampati S; Emrick K; Siegler AJ; Jones J J Acquir Immune Defic Syndr; 2021 May; 87(1):639-643. PubMed ID: 33512848 [TBL] [Abstract][Full Text] [Related]
14. Pre-exposure prophylaxis and bacterial sexually transmitted infections (STIs) among gay and bisexual men. Hart TA; Noor SW; Berlin GW; Skakoon-Sparling S; Tavangar F; Tan D; Lambert G; Grace D; Lachowsky NJ; Jollimore J; Sang J; Parlette A; Lal A; Apelian H; Moore D; Cox J; Sex Transm Infect; 2023 May; 99(3):167-172. PubMed ID: 35701145 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of HIV pre-exposure prophylaxis users at first PrEP counselling visit: the CSL-PrEP cohort. Nozza S; Raccagni AR; Lolatto R; Ceccarelli D; Galli L; Alberton F; Bruzzesi E; Canetti D; Strano M; Ripa M; Bertoni C; Castagna A BMJ Open; 2022 Dec; 12(12):e067261. PubMed ID: 36600429 [TBL] [Abstract][Full Text] [Related]
16. The Impact of First UK-Wide Lockdown (March-June 2020) on Sexual Behaviors in Men and Gender Diverse People Who Have Sex with Men During the COVID-19 Pandemic: A Cross-Sectional Survey. Nadarzynski T; Nutland W; Samba P; Bayley J; Witzel TC Arch Sex Behav; 2023 Feb; 52(2):617-627. PubMed ID: 36344786 [TBL] [Abstract][Full Text] [Related]
17. Changes in HIV Prevention and Sexual Experiences During the COVID-19 Pandemic: A Mixed-Methods Study. Pyra M; Kline J; Taylor O; Rusie L; Schafer T; Motley D; Johnson AK J Acquir Immune Defic Syndr; 2023 Oct; 94(2):143-150. PubMed ID: 37256682 [TBL] [Abstract][Full Text] [Related]
18. Trends in Sexual Behavior and Sexually Transmitted Infections After Initiating Human Immunodeficiency Virus Pre-Exposure Prophylaxis in Men Who Have Sex with Men from Amsterdam, the Netherlands: A Longitudinal Exposure-Matched Study. Coyer L; Prins M; Davidovich U; van Bilsen WPH; Schim van der Loeff MF; Hoornenborg E; Matser A; Boyd A AIDS Patient Care STDS; 2022 Jun; 36(6):208-218. PubMed ID: 35687814 [TBL] [Abstract][Full Text] [Related]
19. Chemsex, sexual behaviour and STI-PrEP use among HIV-PrEP users during the COVID-19 pandemic in Brighton, UK. Ringshall M; Cooper R; Rawdah W; Perera S; Bannister A; Nichols K; Fitzpatrick C; Richardson D Sex Transm Infect; 2022 Jun; 98(4):312. PubMed ID: 34400576 [No Abstract] [Full Text] [Related]
20. Reduced sexual contacts with non-steady partners and less PrEP use among MSM in Belgium during the first weeks of the COVID-19 lockdown: results of an online survey. Reyniers T; Rotsaert A; Thunissen E; Buffel V; Masquillier C; Van Landeghem E; Vanhamel J; Nöstlinger C; Wouters E; Laga M; Vuylsteke B Sex Transm Infect; 2021 Sep; 97(6):414-419. PubMed ID: 33172917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]